LED3 Lecture: Data Science in Drug Discovery

The Leiden Early Drug Discovery & Development (LED3) network is a collaboration between Leiden University’s Institute of Biology (IBL), Leiden Institute of Chemistry (LIC), and the Leiden Academic Centre for Drug Research (LACDR).

LED3 drives the discovery of innovative drug targets, molecules, and concepts to develop safer, more effective treatments for diseases like cancer, cardiovascular, neurodegenerative, and infectious conditions.

By combining expertise across early drug discovery stages, LED3 enhances understanding of molecular and cellular interactions, advancing novel approaches to drug development.

Located near the Leiden Bio Science Park and LUMC, LED3 partners with academia and industry to accelerate drug discovery and development.

Join a lecture by Dr. John Overington of Exscientia, USA.

Dr Overington’s work focuses on integrating machine learning and artificial intelligence to enhance drug discovery processes.

This lecture offers a unique opportunity to gain insights into the role of data science in accelerating drug discovery and development.